Filing Details
- Accession Number:
- 0001232524-17-000185
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-13 17:52:40
- Reporting Period:
- 2017-12-11
- Accepted Time:
- 2017-12-13 17:52:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1253886 | G Patrick Enright | 5Th Fl, Waterloo Exchange Waterloo Rd Dublin 4 L2 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2017-12-11 | 4,500 | $46.83 | 20,839 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2017-12-11 | 4,500 | $81.76 | 25,339 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2017-12-11 | 800 | $138.15 | 24,539 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2017-12-11 | 5,358 | $139.56 | 19,181 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2017-12-11 | 2,842 | $140.50 | 16,339 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Non-Qualified Stock Option (right to buy) | Disposition | 2017-12-11 | 4,500 | $0.00 | 4,500 | $46.83 |
| Ordinary Shares | Non-employee director stock option | Disposition | 2017-12-11 | 4,500 | $0.00 | 4,500 | $81.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-08-08 | No | 4 | M | Direct | |
| 0 | 2023-08-07 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Includes 14,974 shares received as a pro rata liquidating distribution from Longitude Venture Partners, L.P. ("Longitude Venture") and Longitude Capital Associates, L.P. ("Longitude Capital") to their respective partners. In prior reports, the Reporting Person reported indirect ownership of the Issuer's securities held by Longitude Venture and Longitude Capital but disclaimed beneficial ownership except to the extent of his pecuniary interest therein. The Reporting Person is a managing member of Longitude Capital Partners, LLC, the general partner of each of Longitude Venture and Longitude Capital.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.8000 to $138.6800. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $139.1000 to $140.0800. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $140.1700 to $141.1000. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- This non-qualified stock option was granted on August 9, 2012 and vested over a period of one year from the grant date. The options were fully vested as of August 9, 2013.
- This Security is a non-qualified stock option (right to buy).
- This non-qualified stock option was granted on August 8, 2013 and vested over a period of one year beginning on September 1, 2013. The options were fully vested as of August 1, 2014.
Billionaire Hedge Funds
